McKesson stock falls today after 16% earnings surge as traders reassess guidance and spinoff clock (MCK)
McKesson shares fell 2.1% to $937.31 Friday, retreating after a 16.5% surge on an upgraded 2026 profit forecast and plans to spin off its medical-surgical division. Quarterly revenue rose 11% to $106.2 billion, with adjusted EPS up 16% to $9.34. The company filed an automatic shelf registration for future securities sales. TD Cowen raised its price target to $1,012, citing strong oncology and prescription-tech results.